Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Accenture Plc ( ACN - Snapshot Report ) has been awarded a two-year contract. As per the terms of the agreement, the company will deliver consulting services targeted at enhancing the existing healthcare IT systems from the Madrid Health Authority. As per this new contract, Accenture will help Madrid’s public healthcare network that serves the city’s 6.5 million citizens.
Accenture will support Madrid Health Authority to expand the integration and functionality of its healthcare technology systems to over 36 hospitals, which include 29 specialized treatment centers along with 400 primary care facilities. As per the contract, Accenture will take on an advisory role and be involved in full time project management, and thus support Madrid Health Authority’s technology systems.
This latest project will capitalize on the previous work between Accenture and Madrid Health Authority. It will also help the healthcare company achieve its business goals and help citizens with a cost effective healthcare solution.
Over the past decade, Accenture has scored a number of wins in the government segment. However, the company is now focused on deals with better margins. A series of contract wins, at the beginning of 2013 is certainly a good start for Accenture. Apart from Accenture, IBM ( IBM - Analyst Report ) and Hewlett Packard Company ( HPQ - Analyst Report ) have also started aggressive marketing to grab a major chunk of the healthcare market.
The healthcare industry is growing rapidly and offering different employment and business opportunities. A recently-published report from the Bureau of Labor Statistics suggests that December was a huge hiring month for healthcare, with the addition of 45,000 healthcare jobs.
This apart, about 30.0%, or one-third of the nation's total December job growth (to a total of 155,000 jobs) was in the healthcare industry. The growth in the industry is a positive for a leading technology provider such as Accenture, which may be expected to capitalize on the opportunity.
On the other hand, we remain concerned about the federal budget cut. IT research firms, Gartner Inc. ( IT - Snapshot Report ) and IDC anticipate government spending on IT to decline in 2013. This could reduce the amount of deals and eventually put pressure on Accenture.
However, we are optimistic about Accenture’s broad industry exposure as this could mitigate weakness in government spending. Currently, Accenture has a Zacks Rank #3 (Hold).
Read the full Snapshot Report on ACN
Read the full Analyst Report on HPQ
Read the full Analyst Report on IBM
Read the full Snapshot Report on IT